Prevalence of mutations associated with reduced antiretroviral drug susceptibility among human immunodeficiency virus type 1 seroconverters in the United States, 1993-1998.

@article{Weinstock2000PrevalenceOM,
  title={Prevalence of mutations associated with reduced antiretroviral drug susceptibility among human immunodeficiency virus type 1 seroconverters in the United States, 1993-1998.},
  author={Hillard S. Weinstock and Richard Respess and Walid Heneine and Christos J. Petropoulos and Nicholas S Hellmann and Cheng-wang Luo and C. P. Pau and Tina Marie Woods and Marta Gwinn and Jonathan Kaplan},
  journal={The Journal of infectious diseases},
  year={2000},
  volume={182 1},
  pages={
          330-3
        }
}
To assess the prevalence of mutations associated with decreased antiretroviral drug susceptibility, specimens were tested from persons infected with human immunodeficiency virus (HIV) during 1993-1998. Subjects were drug naive and were attending sexually transmitted disease clinics in 6 US cities. All were enrolled consecutively and had tested negative for HIV during the 2 years before enrollment. Plasma specimens from patients having >/=1 reverse transcriptase (RT) or primary protease mutation… CONTINUE READING
Highly Cited
This paper has 36 citations. REVIEW CITATIONS

Citations

Publications citing this paper.
Showing 1-10 of 24 extracted citations

HIV-1 drug resistance and resistance testing.

Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases • 2016
View 1 Excerpt